Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.

International clinical psychopharmacology - 1 Sept 2010

Souza Renan P, Remington Gary, Meltzer Herbert Y, Lieberman Jeffrey A, Kennedy James L, Wong Albert H C

Abstract excerpt

Phosphodiesterase 4B (PDE4B) has been evaluated as a genetic risk factor for schizophrenia. Selective PDE4 inhibitor drugs have antipsychotic-like effects and reduce tardive dyskinesia-like movements in animal models. We investigated whether PDE4B genetic variants are associated with antipsychoti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cyclic Nucleotide Phosphodiesterases, Type 4
Share to Dyskinesia, Drug-Induced

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Haplotypes

Share to Schizophrenia

Share to Sex Factors

Share to Young Adult

Source

Identifiers

PMID: 20436352
DOI: 10.1097/YIC.0b013e32833a5ff9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20436352-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.PMID 20436352Read ↗

PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia.Semantic proximity Read ↗

Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies.Semantic proximity Read ↗

No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.Semantic proximity Read ↗

Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples.Semantic proximity Read ↗

Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patientsSemantic proximity Read ↗

No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes.Semantic proximity Read ↗

The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition.Semantic proximity Read ↗

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.Semantic proximity Read ↗

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms.Semantic proximity Read ↗

Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.Semantic proximity Read ↗

Association study between the neurexin-1 gene and tardive dyskinesia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.